Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
435 GBX | -0.34% | -0.80% | +4.07% |
May. 24 | HSBC cuts Aviva; Deutsche Bank cuts Ryanair | AN |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
Sales 2024 * | 1.65B 2.1B | Sales 2025 * | 1.75B 2.23B | Capitalization | 580M 738M |
---|---|---|---|---|---|
Net income 2024 * | 51M 64.87M | Net income 2025 * | 60M 76.32M | EV / Sales 2024 * | 0.31 x |
Net cash position 2024 * | 71.54M 91M | Net cash position 2025 * | 78.93M 100M | EV / Sales 2025 * | 0.29 x |
P/E ratio 2024 * |
11.4
x | P/E ratio 2025 * |
9.81
x | Employees | 2,654 |
Yield 2024 * |
3.69% | Yield 2025 * |
4.02% | Free-Float | 88.79% |
Latest transcript on SThree plc
1 day | -0.40% | ||
1 week | -0.80% | ||
Current month | +1.99% | ||
1 month | +1.16% | ||
3 months | +2.47% | ||
6 months | +6.10% | ||
Current year | +4.07% |
Managers | Title | Age | Since |
---|---|---|---|
Timo Lehne
CEO | Chief Executive Officer | - | 21-12-31 |
Andrew Beach
DFI | Director of Finance/CFO | 49 | 21-07-04 |
Nick Folkes
COO | Chief Operating Officer | - | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Elaine O'Donnell
BRD | Director/Board Member | 53 | 22-09-30 |
Director/Board Member | - | 22-11-30 | |
James Bilefield
CHM | Chairman | 55 | 17-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 435 | -0.34% | 6 792 |
24-05-30 | 436.5 | +0.34% | 404,226 |
24-05-29 | 435 | +0.81% | 275,781 |
24-05-28 | 431.5 | -1.60% | 395,814 |
24-05-24 | 438.5 | +0.69% | 455,600 |
Delayed Quote London S.E., May 31, 2024 at 05:28 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.07% | 739M | |
-14.05% | 9.36B | |
-27.15% | 6.61B | |
-16.40% | 6.38B | |
-7.86% | 3.49B | |
-6.61% | 3.26B | |
+4.96% | 1.54B | |
+9.73% | 1.49B | |
-6.88% | 1.41B | |
-10.78% | 1.13B |
- Stock Market
- Equities
- STHR Stock